| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d4a95c7328e9c63a07ce2de92c34d8f0 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-282
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate |
2002-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2004-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05e3da560406f791476b0320ab10fd79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7b77c9ead314cb0e8345a4f2a21af79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9dc96f4b047d821c7668bb1ed33a759b |
| publicationDate |
2004-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6673805-B2 |
| titleOfInvention |
Platinum derivative pharmaceutical formulations |
| abstract |
The present invention relates to novel stable solution formulations comprising oxaliplatin alone or in combination with irinotecan (CPT-11), an effective stabilizing amount of lactic acid and/or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier. A method for manufacturing such formulations ready for administration and their use in the antitumor therapy are also within the scope of the invention. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004186172-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009269422-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005233966-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10098813-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11253642-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007197811-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006041012-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8211940-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-1311818-C
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I769126-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008306073-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016058663-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010173988-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7208616-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7795205-B2 |
| priorityDate |
2001-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |